Position in RDY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$179,907
-$39,089 QoQ
Shares Held
12,416
-21.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#168
of 238 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $1,932,764 across 8 Drug Manufacturers - Specialty & Generic names. RDY ranks #8 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
3,613 | $400,825 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,161 | $242,613 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
438 | $237,321 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,395 | $235,113 | |
| 5 | HLN |
Haleon plc
|
24,972 | $232,988 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,648 | $202,747 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,147 | $201,250 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
This page
|
12,416 | $179,907 |
All Filings in RDY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $179,907 | 12,416 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $218,996 | 15,812 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $220,385 | 15,697 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $183,725 | 13,142 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $198,125 | 13,182 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $144,878 | 10,984 | Shares | Other | 2025-05-07 | |
| 2024-12-31 | $212,391 | 13,451 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $217,454 | 2,737 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $205,789 | 2,701 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||